MARC details
000 -LEADER |
fixed length control field |
02130nam a22002657a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20191226214707.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110914t xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9789241564175 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 33.1 E 2011 |
245 00 - TITLE STATEMENT |
Title |
Ensuring balance in national policies on controlled substances : |
Remainder of title |
guidance for availability and accessibility of controlled medicines. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Geneva : |
Name of publisher, distributor, etc. |
World Health Organization, |
Date of publication, distribution, etc. |
2011. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
v, 78 p. : |
Other physical details |
ill. ; |
Dimensions |
30 cm. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This book provides guidance on policies and legislation with regards to availability, accessibility, affordability and control of medicines made from substances regulated under the international drug control conventions, herein referred to as "controlled medicines". Their scope encompasses "all controlled medicines", but with a specific focus on essential medicines. Controlled medicines play an important role in several areas of medicine, including pain treatment, treatment of opioid dependence, emergency obstetrics, psychiatry and neurology. The availability, accessibility and affordability of controlled medicines are important issues for all countries, but problematic for most of them.<br/><br/>This book elaborates on the background and then provides 21 guidelines on various topics: content of drug control legislation and policy; authorities and their role in the system; policy planning for availability and accessibility; healthcare professionals; estimates and statistics; procurement; and nationally listed drugs. Each guideline has an elucidation and a description of the legal context. The Country Assessment Checklist enables the user to determine which guidelines still need work. A CD-ROM provides additional information.<br/><br/>Also endorsed by the International Narcotics Control Board. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug control. |
9 (RLIN) |
4731 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Narcotics. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medical policy. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug and Narcotic Control. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Narcotics. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Prescription Drugs. |
9 (RLIN) |
4737 |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Health Policy. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine Classification |
Koha item type |
WHO Publications |